The Spell of Cox­iella

by Elio

A few years ago, we cel­e­brated one of the pret­ti­est dis­cov­er­ies in mod­ern mi­cro­bi­ol­ogy, achiev­ing the growth of Cox­iella bur­netii out­side its host cells in lab­o­ra­tory me­dia (see Cox­iella Es­capes from Cell!). The ex­cite­ment was jus­ti­fied, as this or­gan­ism had been a pro­to­type of a strictly in­tra­cel­lu­lar or­gan­ism. Best I know, it does not nat­u­rally grow out­side of cells, de­spite hav­ing the abil­ity to do so.

Par­tic­u­larly in­spir­ing is that cul­ti­va­tion in vitro was achieved by gaz­ing at its genome se­quence and thereby gain­ing a sense of its meta­bolic needs. A fairly straight­for­ward medium con­tain­ing amino acids and a par­tic­u­larly high con­cen­tra­tion of cys­teine along with a low oxy­gen ten­sion (2.5% O2) did the trick (Fig­ure 1). These host-free-cul­tured cells re­tain their vir­u­lence. By now, the use of ax­enic growth tech­nique to grow C. bur­netii has be­come com­mon­place.

Fig­ure 1. Colonies of C. bur­netii on the sur­face of agar af­ter 14 days in­cu­ba­tion in a 2.5% oxy­gen at­mos­phere. They are tiny, 0.05 – 0.1 mm in di­am­e­ter. Source

A pa­per with the provoca­tive ti­tle "Hor­i­zon­tally Ac­quired Biosyn­the­sis Genes Boost Cox­iella burnetii's Phys­i­ol­ogy" ap­peared re­cently. Hor­i­zon­tal gene trans­fer (HGT) in a nor­mally in­tra­cel­lu­lar or­gan­ism? Where did these genes come from? Did these se­questered or­gan­isms have con­ju­gal vis­its? Not likely, so the ac­qui­si­tion of new genes must have hap­pened be­fore the cox­iel­lae be­came pris­on­ers. C. bur­netii seems to be de­rived from its clos­est rel­a­tives, tick-as­so­ci­ated cox­iel­lae, which are be­nign en­dosym­bionts that ap­pear to con­tribute to the nu­tri­tion of their hosts. An­tibi­otic treat­ment makes the ticks less fit. The au­thors say: "…this cor­pus of data demon­strates that C. bur­netii re­cently evolved from an in­her­ited sym­biont of ticks which suc­ceeded in in­fect­ing ver­te­brate cells, likely by the ac­qui­si­tion of novel vir­u­lence fac­tors." The in­fer­ence is that HGT took place be­fore that, most likely even be­fore the or­gan­ism be­came a sym­biont of ticks.

It is widely be­lieved that HGT is a ma­jor — prob­a­bly the ma­jor — ac­tor in prokary­otic evo­lu­tion. We at STC have de­voted quite a bit of space to it (See the post by Christoph Un Tour d'Horizon (1/3). But do not dis­dain the other two pieces of his tril­ogy — here and here). An ad­van­tage of study­ing HGT in cox­iel­lae is that, like many en­dosym­bionts, they have a re­duced genome (C. bur­netii has ~2 Mbp) and, due to se­lec­tion against un­needed genes, most of the ones present can be ex­pected to be con­se­quen­tial in the organism's par­tic­u­lar en­vi­ron­ment.

The au­thors used strin­gent cri­te­ria to iden­tify genes ac­quired by HGT. This is not easy be­cause C. bur­netii has few close rel­a­tives (Le­gionella and two other mem­bers of the Le­gionel­lales, all within the Gammapro­teobac­te­ria). Be­cause of the un­cer­tain­ties in the tax­o­nomic posi­ton of C. bur­netii, the re­searchers ex­cluded genes that may have come from close rel­a­tives. They were left with 172 genes that they iden­ti­fied with high con­fi­dence as be­ing 'HGT-niks'. Cu­ri­ously, none of these were car­ried in the plas­mids of this or­gan­ism. The iden­ti­fi­able genes have rel­a­tives in other bac­te­ria, about half be­ing found in mem­bers of the pro­teobac­te­ria (al­pha, beta, delta/epsilon), in keep­ing with the rule that HGT takes place more fre­quently among re­lated species. These in­trigu­ing genes in­clude some that en­code for Type IV pili, struc­tures that, for ex­am­ple, en­able Acine­to­bac­ter bau­manii to sop up DNA from the en­vi­ron­ment. Does this mean that C. bur­netii used this mech­a­nism for its HGT? Could be.

Some of the HGT genes are clus­tered, thus ap­pear to have been trans­ferred en bloc. The au­thors ze­roed in on one par­tic­u­lar clus­ter in­volved in the biosyn­the­sis of LPS that ap­pears to have been ac­quired in a sin­gle event, pos­si­bly from some other gammapro­teobac­terium. LPS is the best demon­strated vir­u­lence fac­tor in this or­gan­ism (there are many oth­ers by now, see here). So, this or­gan­ism joins the long list of those whose bac­te­r­ial vir­u­lence fac­tors have been ac­quired by HGT.

The in­ves­ti­ga­tors found two other sets of genes, one set in­volved in fatty acid and bi­otin biosyn­the­sis, the other in mak­ing heme. The fatty acid genes prob­a­bly orig­i­nated in a deltapro­teobac­terium or a spiro­chete. The arrange­ment of these genes is prac­ti­cally the same as in Spiro­cheta africana (again, sug­gest­ing that they were trans­ferred si­mul­ta­ne­ously). In ad­di­tion, C. bur­netii ob­tained via HGT genes for pyru­vate de­hy­dro­ge­nases, en­zymes that con­vert pyru­vate into acetyl-CoA (which is needed for fatty acid syn­the­sis as well as ATP gen­er­a­tion). C. bur­netii also has two copies of the gene re­quired for bi­otin biosyn­the­sis, one be­ing of HGT ori­gin. In­hibit­ing the func­tion of sev­eral of these genes de­creased growth fit­ness in vitro.

Fig­ure 2 Cox­iella bur­netii binds to macrophages through αvβ3 in­te­grin, which trig­gers phago­cy­to­sis through an actin-de­pen­dent mech­a­nism. The nascent Cox­iella-con­tain­ing vac­uole (CCV) acid­i­fies to pH ~5.4, which is char­ac­ter­is­tic of nor­mal phago­so­mal de­vel­op­ment. By con­trast to phago­somes, the CCV also ac­quires mi­cro­­tu­bule-as­so­ci­ated pro­tein light-chain 3 (LC3; an au­tophagosomal marker), a process that is de­pendent on bac­te­r­ial pro­tein syn­the­sis. The nas­cent CCV de­vel­ops through fu­sion and fis­sion events with early en­do­somes and then late en­do­somes in con­cur­rence with a fur­ther aci­di­fi­cation to pH 5, which is char­ac­ter­is­tic of nor­mal phago­so­mal de­vel­op­ment. Lyso­so­mal en­zymes, in­clud­ing cathep­sin D (CTSD), start ac­cu­mulating in the CCV by 2 hours af­ter in­ter­na­li­zation, at which point the vac­uole is at pH ~4.5. This pause in CCV de­vel­op­ment might al­low con­version of the bac­te­ria from small cell va­ri­ants (SCVs) to the meta­bol­i­cally ac­tive large cell vari­ants (LCVs). Be­tween 8 hours and 2 days af­ter in­ter­na­li­za­tion, the CCV ex­pands to oc­cupy an in­creas­ingly dom­i­nant por­tion of the cy­to­plas­mic space of the host cell. RHO GT­Pase is likely to be in­volved in main­te­nance of the large vac­uole, whereas the re­cruit­ment of RAB1B from the ER might fa­cil­i­tate the ac­qui­si­tion of ad­di­tional mem­branes to cre­ate this spa­cious CCV. Source

The story of the heme genes has an in­ter­est­ing twist. I was not aware that reg­u­la­tion of heme biosyn­the­sis in­volves a tRNA, namely tRNAglu. It works this way: the first step in the syn­the­sis of heme is cat­alyzed in many bac­te­ria by glu­tamyl-tRNA re­duc­tase and glu­ta­mate semi­alde­hyde amino­trans­ferase, en­zymes that con­vert glu­ta­mate into gamma-aminole­vulinic acid, the uni­ver­sal pre­cur­sor of heme (these en­zymes and their con­nec­tion to heme make for an in­ter­est­ing story in it­self, see here). In C. bur­netii, this tRNA is not used in pro­tein syn­the­sis but seems to be ded­i­cated to heme pro­duc­tion. Mu­tants in this C. bur­netii tRNAglu grow poorly (this or­gan­ism can­not take up heme from the out­side). In­ter­est­ingly, this tRNA is not present in the non-path­o­genic tick cox­iel­lae. The au­thors sug­gest that heme biosyn­the­sis could be a tar­get for anti-cox­iel­lal ther­apy.

Now, you may well ask, does this work fur­ther our un­der­stand­ing of the mech­a­nism in­volved in Cox­iella patho­gen­e­sis? Per­haps not di­rectly, but it adds to the reper­toire of things we know about this or­gan­ism. As we wrote ear­lier, this bac­terium is the agent of a some­what rare dis­ease called Q fever (Q is for 'query', even though Queens­land is where it was first de­scribed). Q fever is a world­wide de­bil­i­tat­ing dis­ease, some­thing like a re­ally bad flu, which af­fects both hu­mans and do­mes­tic an­i­mals. It's highly con­ta­gious and highly in­fec­tive — per­haps a sin­gle cell can cause dis­ease. It is clas­si­fied as a class B bioter­ror­ism agent that has been weaponized and mass-pro­duced un­der var­i­ous bi­o­log­i­cal war­fare pro­grams. Q fever is a zoono­sis, ac­quired most of­ten by in­hala­tion from in­fected cat­tle and other do­mes­tic an­i­mals.

The most no­table fea­ture of C. bur­netii patho­gen­e­sis is the bacterium's unique abil­ity to sur­vive and even thrive in acidic lyso­somes, sites that are ex­tremely in­im­i­cal to all other known bac­te­ria. One can say that C. bur­netii breaks many of the rules for in­tra­cel­lu­lar life. Within its vac­uoles (known as Cox­iella-Con­tain­ing Vac­uoles, or CCVs), the or­gan­isms pro­lif­er­ate to the ex­tent that a CCV can nearly fill the cell. Quite a bit is known about the var­i­ous steps in patho­gen­e­sis. The or­gan­isms are 'stealth pathogens' that avoid caus­ing an in­flam­ma­tory re­sponse (which could be lethal to them). See Fig­ure 2 for de­tails of the steps in patho­gen­e­sis. No­table is that cox­iel­lal LPS is about 1000x less en­do­toxic than usual for this mol­e­cule but this doesn't mean that other of its ac­tiv­i­ties are im­paired, such as help­ing in evad­ing the im­mune re­sponse and aid­ing in be­ing taken up by cells. The organism's abil­ity to evade an im­mune re­sponse is con­nected to the fact that they in­hibit apop­to­sis.

Just how to tie to­gether these facts to the HGT story is not yet clear, but it can be as­sumed with con­fi­dence that fur­ther progress will be made in the un­der­stand­ing how this un­usual pathogen causes dis­ease.

 

This topic was dis­cussed on This Week in Mi­cro­bi­ol­ogy Episode # 155 (be­low)

 

 

Other Posts